Equities

Heartbeam Inc

BEAT:NAQ

Heartbeam Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)2.26
  • Today's Change-0.096 / -4.06%
  • Shares traded39.14k
  • 1 Year change+74.18%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 18:53 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

HeartBeam, Inc. is a cardiac technology company. The Company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The Company is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms.

  • Revenue in USD (TTM)0.00
  • Net income in USD-16.91m
  • Incorporated2015
  • Employees15.00
  • Location
    Heartbeam Inc2118 Walsh Ave., Suite 210SANTA CLARA 95050United StatesUSA
  • Phone+1 (408) 899-4443
  • Fax+1 (302) 655-5049
  • Websitehttps://www.heartbeam.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Rapid Micro Biosystems Inc26.17m-48.40m53.79m193.00--0.6358--2.06-1.11-1.110.60281.970.20451.326.78135,595.90-37.81---43.12---4.82---184.93--4.19------31.44--13.71------
Lucid Diagnostics Inc3.80m-54.15m53.99m70.00------14.21-1.23-1.230.08570.32380.0992--38.9754,285.71-121.82---274.96---67.39---1,227.76--1.71--0.4178--544.03--6.24------
Milestone Scientific Inc8.42m-4.62m54.11m17.00--6.79--6.42-0.0614-0.06140.10960.1030.72740.576314.32495,440.60-40.16-55.48-56.48-74.7272.4463.97-55.21-88.941.81--0.0007--11.600.423320.41---7.99--
Apyx Medical Corp48.54m-28.44m55.59m252.00--4.30--1.15-0.821-0.8211.400.31870.80791.893.78192,627.00-47.47-25.24-57.09-29.9760.4166.11-58.76-46.004.52-5.970.7518--17.6125.8219.28--7.99--
Nutriband Inc1.80m-7.24m56.04m13.00--4.50--31.07-0.8122-0.81220.19841.120.15356.2912.38---61.64-55.21-67.30-66.7433.6233.32-401.62-315.876.36--0.0156--0.274153.43-22.35--65.57--
Singular Genomics Systems Inc2.72m-91.89m57.33m255.00--0.4156--21.06-37.37-37.371.1155.270.01080.286711.5310,674.51-36.46---38.85---41.11---3,375.72--8.04--0.0696--280.52---4.34------
Alpha Pro Tech, Ltd.59.29m4.14m57.74m124.0014.330.926511.290.9740.36640.36645.245.670.85961.689.07478,121.006.0115.216.2216.0639.5540.236.9912.9311.21--0.000.00-1.215.6027.642.935.50--
IR-Med Inc0.00-3.47m58.01m6.00--159.71-----0.0499-0.04990.000.00510.00----0.00-197.95---273.36--------------0.3019-------3.70------
Medinotec Inc8.38m-21.86k58.67m35.00----755.657.00-0.0019-0.00190.71460.21561.645.0217.62239,561.70-0.4275---0.5122--42.89---0.2607--2.326.610.3165--402.25---14.73------
InspireMD Inc6.57m-25.52m61.31m65.00--1.29--9.34-0.7389-0.73890.19071.860.12022.574.73101,030.80-46.71-60.59-52.36-72.9723.8520.46-388.67-334.787.13--0.00--20.0011.50-7.71--41.57--
Pheton Holdings Ltd628.59k-241.22k61.99m11.00--170.44--98.61-0.0201-0.02010.05240.0255------57,144.55--------74.90---38.37--0.3984--0.00---7.53---387.24------
Heartbeam Inc0.00-16.91m62.93m15.00--7.20-----0.6375-0.63750.000.32780.00----0.00-106.50---113.62--------------0.00-------12.94------
iCAD Inc18.80m-4.54m63.70m67.00--2.04--3.39-0.1735-0.0880.71851.170.44881.063.14280,537.30-10.84-23.94-13.90-34.1486.0476.96-24.16-45.024.13--0.00---12.54-7.5329.32--23.88--
Vicarious Surgical Inc0.00-61.02m65.70m131.00--0.9116-----10.77-10.770.0012.220.00----0.00-61.68---66.62--------------0.00-------1,478.15------
Hyperfine Inc11.94m-41.45m67.61m131.00--1.01--5.66-0.5773-0.57730.16630.92480.12620.98562.5691,160.30-43.81---48.08--44.51---347.05--7.24--0.00--61.90--39.54------
Vivani Medical Inc0.00-24.20m69.07m44.00--2.90-----0.4643-0.46430.000.43160.00----0.00-44.89-56.58-50.97-67.66-------2,868.72----0.00-------84.69--40.33--
Data as of Nov 13 2024. Currency figures normalised to Heartbeam Inc's reporting currency: US Dollar USD

Institutional shareholders

7.29%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 2024700.54k2.64%
Smith, Salley & Associates LLCas of 30 Sep 2024250.00k0.94%
Geode Capital Management LLCas of 30 Jun 2024213.09k0.80%
UBS Financial Services, Inc.as of 30 Jun 2024160.00k0.60%
Ritholtz Wealth Management LLCas of 30 Sep 2024139.18k0.52%
Beacon Pointe Advisors LLCas of 30 Jun 2024133.33k0.50%
1919 Investment Counsel LLCas of 30 Jun 2024100.00k0.38%
Kestra Private Wealth Services LLCas of 30 Jun 202491.02k0.34%
Cannon Financial Strategists, Inc.as of 30 Sep 202480.39k0.30%
SSgA Funds Management, Inc.as of 30 Jun 202469.57k0.26%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.